220 related articles for article (PubMed ID: 30771698)
21. Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial.
Briganti A; Gandaglia G; Scuderi S; Gallina A; Colombo R; Fossati N; Barletta F; Pellegrino A; Nocera L; Montorsi F; Necchi A
Eur Urol; 2020 May; 77(5):576-580. PubMed ID: 31911010
[TBL] [Abstract][Full Text] [Related]
22. Morbidity and mortality after robot-assisted radical cystectomy with intracorporeal urinary diversion in octogenarians: results from the European Association of Urology Robotic Urology Section Scientific Working Group.
Mortezavi A; Crippa A; Edeling S; Pokupic S; Dell'Oglio P; Montorsi F; D'Hondt F; Mottrie A; Decaestecker K; Wijburg CJ; Collins J; Kelly JD; Tan WS; Sridhar A; John H; Canda AE; Schwentner C; Rönmark EP; Wiklund P; Hosseini A
BJU Int; 2021 May; 127(5):585-595. PubMed ID: 33058469
[TBL] [Abstract][Full Text] [Related]
23. Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma.
Crozier J; Papa N; Perera M; Stewart M; Goad J; Sengupta S; Bolton D; Lawrentschuk N
Investig Clin Urol; 2017 Nov; 58(6):416-422. PubMed ID: 29124240
[TBL] [Abstract][Full Text] [Related]
24. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
Simone G; Papalia R; Ferriero M; Guaglianone S; Castelli E; Collura D; Muto G; Gallucci M
Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939
[TBL] [Abstract][Full Text] [Related]
25. Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched Analysis.
Deuker M; Krimphove MJ; Stolzenbach LF; Collà Ruvolo C; Nocera L; Mansour M; Tian Z; Roos FC; Becker A; Kluth LA; Shariat SF; Black PC; Kassouf W; Tilki D; Saad F; Chun FKH; Karakiewicz PI
Clin Genitourin Cancer; 2021 Aug; 19(4):e264-e271. PubMed ID: 33972185
[TBL] [Abstract][Full Text] [Related]
26. Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: a population-based study.
Siemens DR; Mackillop WJ; Peng Y; Wei X; Berman D; Booth CM
Urol Oncol; 2015 Oct; 33(10):425.e15-23. PubMed ID: 26199175
[TBL] [Abstract][Full Text] [Related]
27. Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy.
Moschini M; Mattei A; Cornelius J; Shariat SF; Dell'Oglio P; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
World J Urol; 2018 Apr; 36(4):639-644. PubMed ID: 29368231
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
[TBL] [Abstract][Full Text] [Related]
29. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
[TBL] [Abstract][Full Text] [Related]
30. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
[TBL] [Abstract][Full Text] [Related]
31. Determinants of adequate lymph node dissection following neoadjuvant chemotherapy in patients with urothelial muscle-invasive bladder cancer: results from the National Cancer Database.
Monaghan TF; Flores VX; Suss NR; Robins DJ; Smith MT; McNeil BK; Hyacinthe LM; Weiss JP; Winer AG
Int Urol Nephrol; 2021 Feb; 53(2):235-239. PubMed ID: 32865771
[TBL] [Abstract][Full Text] [Related]
32. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.
Hautmann RE; de Petriconi RC; Pfeiffer C; Volkmer BG
Eur Urol; 2012 May; 61(5):1039-47. PubMed ID: 22381169
[TBL] [Abstract][Full Text] [Related]
33. Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer.
Perera M; McGrath S; Sengupta S; Crozier J; Bolton D; Lawrentschuk N
Nat Rev Urol; 2018 Nov; 15(11):686-692. PubMed ID: 30104615
[TBL] [Abstract][Full Text] [Related]
34. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer.
Fang AC; Ahmad AE; Whitson JM; Ferrell LD; Carroll PR; Konety BR
Cancer; 2010 Apr; 116(8):1901-8. PubMed ID: 20186823
[TBL] [Abstract][Full Text] [Related]
35. How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder.
Palumbo C; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Antonelli A; Karakiewicz PI
Urol Oncol; 2019 Dec; 37(12):893-899. PubMed ID: 31296422
[TBL] [Abstract][Full Text] [Related]
36. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes.
Bochner BH; Dalbagni G; Marzouk KH; Sjoberg DD; Lee J; Donat SM; Coleman JA; Vickers A; Herr HW; Laudone VP
Eur Urol; 2018 Oct; 74(4):465-471. PubMed ID: 29784190
[TBL] [Abstract][Full Text] [Related]
37. Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer.
Moschini M; Arbelaez E; Cornelius J; Mattei A; Shariat SF; Dell Oglio P; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
Urol Oncol; 2018 Jun; 36(6):307.e9-307.e14. PubMed ID: 29602638
[TBL] [Abstract][Full Text] [Related]
38. [Effects of performing pelvic lymph node dissection before versus after radical cystectomy].
Zhu ZS; Ye M; Shi HQ; Zhou YB; Chen LY; Liu QQ; Zhang CT; Lou RL; Xu LZ
Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(32):2574-7. PubMed ID: 24351600
[TBL] [Abstract][Full Text] [Related]
39. The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes.
Moschini M; Shariat SF; Abufaraj M; Soria F; Klatte T; Croce G; Mattei A; Damiano R; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
Urol Oncol; 2017 Apr; 35(4):151.e17-151.e23. PubMed ID: 27932269
[TBL] [Abstract][Full Text] [Related]
40. Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect in bladder cancer.
Sodagum L; Passarelli R; Pfail J; Patel HV; Chua K; Doppalapudi SK; Golombos D; Elsamra SE; Singer EA; Jang TL; Srivastava A; Ghodoussipour S
Urol Oncol; 2024 Jan; 42(1):21.e9-21.e20. PubMed ID: 37953186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
